Erika Folestad

1.3k total citations
16 papers, 927 citations indexed

About

Erika Folestad is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Erika Folestad has authored 16 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Erika Folestad's work include Cancer, Hypoxia, and Metabolism (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Congenital heart defects research (2 papers). Erika Folestad is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Congenital heart defects research (2 papers). Erika Folestad collaborates with scholars based in Sweden, United States and Australia. Erika Folestad's co-authors include Ulf Eriksson, Kristian Pietras, Christer Betsholtz, Linda Fredriksson, Dick Wågsäter, Enming J. Su, Daniel A. Lawrence, Kris Mann, Annica Pontén and Anne Kunath and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and PLoS ONE.

In The Last Decade

Erika Folestad

16 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erika Folestad Sweden 12 353 196 152 151 147 16 927
Chun-Man Yuen Taiwan 19 445 1.3× 154 0.8× 133 0.9× 138 0.9× 205 1.4× 30 1.1k
Enming J. Su United States 19 491 1.4× 299 1.5× 107 0.7× 337 2.2× 300 2.0× 36 1.4k
Laurel S. Kleppe United States 20 472 1.3× 127 0.6× 165 1.1× 171 1.1× 70 0.5× 32 1.4k
Fengyan Jin China 24 660 1.9× 154 0.8× 108 0.7× 298 2.0× 199 1.4× 69 1.4k
Leorah Ross United States 7 931 2.6× 188 1.0× 136 0.9× 266 1.8× 61 0.4× 23 1.6k
Mary Jo Mulligan‐Kehoe United States 18 616 1.7× 168 0.9× 227 1.5× 188 1.2× 53 0.4× 26 1.5k
Yeon Hee Cho South Korea 13 411 1.2× 96 0.5× 97 0.6× 188 1.2× 56 0.4× 17 743
Jeffrey D. Klopfenstein United States 23 323 0.9× 282 1.4× 192 1.3× 240 1.6× 175 1.2× 63 1.5k
Dan Zhu China 13 226 0.6× 87 0.4× 94 0.6× 83 0.5× 45 0.3× 52 728
Wei Bai China 22 439 1.2× 329 1.7× 106 0.7× 234 1.5× 125 0.9× 39 1.2k

Countries citing papers authored by Erika Folestad

Since Specialization
Citations

This map shows the geographic impact of Erika Folestad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Folestad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Folestad more than expected).

Fields of papers citing papers by Erika Folestad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Folestad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Folestad. The network helps show where Erika Folestad may publish in the future.

Co-authorship network of co-authors of Erika Folestad

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Folestad. A scholar is included among the top collaborators of Erika Folestad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Folestad. Erika Folestad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Folestad, Erika & Annelie Falkevall. (2024). “Regulation of adipose-derived fatty acid flux to the liver”-Impact on metabolic dysfunction-associated steatotic liver disease. Current Opinion in Endocrine and Metabolic Research. 37. 100559–100559. 1 indexed citations
2.
Folestad, Erika, Annika Mehlem, Hannes Olauson, et al.. (2024). Vascular endothelial growth factor B-mediated fatty acid flux in the adipose-kidney axis contributes to lipotoxicity in diabetic kidney disease. Kidney International. 107(3). 492–507. 2 indexed citations
3.
Falkevall, Annelie, Annika Mehlem, Erika Folestad, et al.. (2023). Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue. Journal of Hepatology. 78(5). 901–913. 33 indexed citations
4.
Folestad, Erika, Anne Kunath, & Dick Wågsäter. (2018). PDGF-C and PDGF-D signaling in vascular diseases and animal models. Molecular Aspects of Medicine. 62. 1–11. 82 indexed citations
5.
Vorkapić, Emina, et al.. (2018). Plasma cholesterol lowering in an AngII‑infused atherosclerotic mouse model with moderate hypercholesterolemia. International Journal of Molecular Medicine. 42(1). 471–478. 3 indexed citations
6.
Muhl, Lars, Erika Folestad, Yixin Wang, et al.. (2017). Neuropilin 1 binds PDGF-D and is a co-receptor in PDGF-D–PDGFRβ signaling. Journal of Cell Science. 130(8). 1365–1378. 46 indexed citations
7.
Shang, Ming-Mei, Christine Moessinger, Hassan Foroughi Asl, et al.. (2017). Poliovirus Receptor–Related 2. Arteriosclerosis Thrombosis and Vascular Biology. 37(3). 534–542. 21 indexed citations
8.
Chang, Ya-Ting, Lars Muhl, Bàrbara Laviña, et al.. (2017). Extracellular retention of PDGF-B directs vascular remodeling in mouse hypoxia-induced pulmonary hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology. 314(4). L593–L605. 9 indexed citations
9.
Buhl, Eva Miriam, Sonja Djudjaj, Janka Bábíčková, et al.. (2016). The role of PDGF-D in healthy and fibrotic kidneys. Kidney International. 89(4). 848–861. 42 indexed citations
10.
Cortez, Eliane, Sebastian Braun, Matteo Bocci, et al.. (2016). Functional malignant cell heterogeneity in pancreatic neuroendocrine tumors revealed by targeting of PDGF-DD. Proceedings of the National Academy of Sciences. 113(7). E864–73. 33 indexed citations
11.
Folestad, Erika, et al.. (2016). Mice Lacking Platelet-Derived Growth Factor D Display a Mild Vascular Phenotype. PLoS ONE. 11(3). e0152276–e0152276. 36 indexed citations
12.
Su, Enming J., Linda Fredriksson, Shannon J. Moore, et al.. (2015). Imatinib treatment reduces brain injury in a murine model of traumatic brain injury. Frontiers in Cellular Neuroscience. 9. 385–385. 39 indexed citations
13.
Johnson, Jill R., Erika Folestad, Simone A. Walker, et al.. (2015). Pericytes contribute to airway remodeling in a mouse model of chronic allergic asthma. American Journal of Physiology-Lung Cellular and Molecular Physiology. 308(7). L658–L671. 40 indexed citations
14.
Ehnman, Monika, Edoardo Missiaglia, Erika Folestad, et al.. (2013). Distinct Effects of Ligand-Induced PDGFRα and PDGFRβ Signaling in the Human Rhabdomyosarcoma Tumor Cell and Stroma Cell Compartments. Cancer Research. 73(7). 2139–2149. 73 indexed citations
15.
Su, Enming J., Linda Fredriksson, Melissa Geyer, et al.. (2008). Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nature Medicine. 14(7). 731–737. 359 indexed citations
16.
Pontén, Annica, Erika Folestad, Kristian Pietras, & Ulf Eriksson. (2005). Platelet-Derived Growth Factor D Induces Cardiac Fibrosis and Proliferation of Vascular Smooth Muscle Cells in Heart-Specific Transgenic Mice. Circulation Research. 97(10). 1036–1045. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chun-Man Yuen Breakdown of academic impact, for papers by Enming J. Su Breakdown of academic impact, for papers by Laurel S. Kleppe Breakdown of academic impact, for papers by Fengyan Jin Breakdown of academic impact, for papers by Leorah Ross Breakdown of academic impact, for papers by Mary Jo Mulligan‐Kehoe Breakdown of academic impact, for papers by Yeon Hee Cho Breakdown of academic impact, for papers by Jeffrey D. Klopfenstein Breakdown of academic impact, for papers by Dan Zhu Breakdown of academic impact, for papers by Wei Bai
Rankless by CCL
2026